New Study Paper: Absorption, metabolism and excretion of opicapone in human healthy volunteers
Nand Singh, Medical Director contributions to Bial Study Paper. This paper documents the study - absorption, metabolism and excretion of opicapone (2,5-dichloro-3-(5-[3,4-dihydroxy-5-nitrophenyl]-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine 1-oxide), a selective catechol-O-methyltransferase inhibitor investigations.
Matt Paterson featured in Pharma Manufacturing - 2022 Pharma Predictions
Quotient's Vice President of Corporate Strategy has been featured in the 2022 Pharma Predictions article on Pharma Manufacturing.
Pharmaceutical Technology interview with Paul Quigley, Head of Production, Drug Substance on timeline acceleration with drug substance and drug product
Quotient's Head of Production, Drug Substance, Paul Quigley was featured in a interview with Pharmaceutical Technology regarding the acceleration of development timelines between drug substance and drug product.
Quotient Drug Development Experts Featured in Biopharmaceutics Textbook
Quotient Sciences drug development experts, Chris Roe & Vanessa Zann, are contributing co-authors in new biopharmaceutics textbook. Published by Wiley, "Biopharmaceutics - From Fundamentals to Industrial Practice," was written by a group of distinguished Scientists from the UK's Academy of Pharmaceutical Sciences Biopharmaceutica Focus Group and edited by Professor of Biopharmaceutics, Hannah Batchelor. The textbook is designed to deliver a comprehensive examination of the tools used within the field of biopharmaceutics and their applications to drug development.
Quotient Sciences to Present on Tufts CSDD Study of Translational Pharmaceutics at Biotech Showcase 2020 in San Francisco
Quotient Sciences, today announced plans to present on the latest Tufts CSDD White Paper assessing the timeline reductions and multi-million dollar cost savings of Translational Pharmaceutics® at Biotech Showcase 2020™, to be held January 13-15, during the most important week in healthcare at the Hilton San Francisco Union Square.
Quotient Clinical hosts formulation development and drug delivery seminar series
Quotient Sciences is holding a series of formulation development and drug delivery seminars this June and July. The seminars will take place at major life science hubs in the UK and USA, and will address the most pressing challenges currently faced by pharmaceutical and biotechnology companies in early drug development.